CAS 1174018-99-5: Relebactam
Description:Relebactam is a synthetic beta-lactamase inhibitor that is primarily used in combination with other antibiotics to enhance their efficacy against resistant bacterial strains. It is particularly effective against certain Gram-negative bacteria that produce beta-lactamase enzymes, which can inactivate many beta-lactam antibiotics. Relebactam is characterized by its ability to inhibit the activity of class A and some class C beta-lactamases, thereby restoring the activity of co-administered beta-lactam antibiotics like meropenem. The compound has a molecular formula that reflects its complex structure, which includes a beta-lactam ring, a key feature that contributes to its mechanism of action. Relebactam is typically administered intravenously and is being investigated for its potential in treating serious infections caused by multidrug-resistant organisms. Its development is part of a broader effort to combat antibiotic resistance, a significant public health challenge. As with many pharmaceuticals, the safety and efficacy of Relebactam are evaluated through clinical trials before it is approved for widespread clinical use.
Formula:C12H20N4O6S
InChI:InChI=1S/C12H20N4O6S/c17-11(14-8-3-5-13-6-4-8)10-2-1-9-7-15(10)12(18)16(9)22-23(19,20)21/h8-10,13H,1-7H2,(H,14,17)(H,19,20,21)/t9-,10+/m1/s1
InChI key:InChIKey=SMOBCLHAZXOKDQ-ZJUUUORDSA-N
SMILES:O=C1N(OS(=O)(=O)O)C2CN1C(C(=O)NC3CCNCC3)CC2
- Synonyms:
- Relebactam
- (2S,5R)-7-oxo-2-(piperidin-1-ium-4-ylcarbamoyl)-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate
- (2S,5R)-sulfuric acid mono{[(4-aminopiperidin-4-yl)carbonyl]-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl}ester
- Sulfuric acid Mono-[7-oxo-2-(piperidin-4-ylcarbaMoyl)-1,6-diaza-bicyclo[3.2.1]oct-6-yl] ester
- Sulfuric acid mono[(1R,2S,5R)-7-oxo-2-[(4-piperidinylamino)carbonyl]-1,6-diazabicyclo[3.2.1]oct-6-yl] ester
- Sulfuric acid, mono[(1R,2S,5R)-7-oxo-2-[(4-piperidinylamino)carbonyl]-1,6-diazabicyclo[3.2.1]oct-6-yl] ester
- MK 7655